A PHASE 1/2 DOSE ESCALATION SAFETY, PHARMACOKINETIC AND EFFICACY STUDY OF MULTIPLE INTRAVENOUS ADMINISTRATIONS OF A HUMANIZED MONOCLONAL ANTIBODY (SAR650984) AGAINST CD38 IN PATIENTS WITH SELECTED CD38+ HEMATOLOGICAL MALIGNANCIES

计划入组 3 人

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

计划入组 0 人

Companion Pharmacogenetic Study to UMCC 9900/9901

首次发布于 2005 年 9 月 5 日

BDP-8900

CG-8900

rPOC-0900

Medit and Graphy Form Strategic Alliance to Transform Digital Orthodontics with 3D-Printed Clear Aligners

Nanobiotix's Radioenhancer JNJ-1900 Enters Phase 2 Trial for Unresectable NSCLC

JNJ-1900 Shows Promise in Phase 1 Trial for Advanced Pancreatic Cancer